GenMark Diagnostics Inc. | Mutual Funds
Mutual Funds that own GenMark Diagnostics Inc.
T Rowe Price New Horizons Fund
3,940,988
7.07%
-10,300
0.14%
06/30/2018
T Rowe Price Health Sciences Fund
3,298,299
5.92%
0
0.22%
06/30/2018
Fidelity Select Health Care Portfolio
2,500,000
4.48%
0
0.28%
07/31/2018
Putnam Equity Spectrum Fund
2,377,512
4.26%
-418,900
2.44%
06/30/2018
Fidelity Select Medical Equipment & Systems Portfolio
2,090,000
3.75%
0
0.32%
07/31/2018
JPMorgan Funds - Global Healthcare Fund
1,726,029
3.1%
-10,700
0.5%
05/31/2018
Fidelity Growth Company Fund
1,472,352
2.64%
-7,989
0.03%
07/31/2018
JPMorgan Small Cap Growth Fund
1,386,909
2.49%
-41,725
0.47%
07/31/2018
Vanguard Total Stock Market Index Fund
1,346,005
2.41%
0
0%
07/31/2018
iShares Russell 2000 ETF
1,105,916
1.98%
-591
0.02%
09/06/2018
| Address |
5964 La Place Court
Carlsbad California 92008
United States
|
|
Employees
|
- |
| Website |
http://www.genmarkdx.com |
| Updated |
07/08/2019 |
| GenMark Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of proprietary eSensor electrochemical detection technology. It also manufactures, sells, and supports instruments and molecular tests. The company was founded by Jon Faiz Kayyem on February 12, 2010 and is headquartered in Carlsbad, CA. |
